EURAD MRI Classification of US Indeterminate Adnexa Lesions
| Status: | Recruiting |
|---|---|
| Conditions: | Ovarian Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/19/2018 |
| Start Date: | February 2014 |
| End Date: | February 2021 |
| Contact: | Gemma Gliori, MS |
| Email: | ggliori@uwhealth.org |
| Phone: | 608.262.7269 |
European Multicenter Validation of an ADNEXMR SCORING System for Characterizing Adnexal Masses: EURAD-MR Classification
This research is targeting patients with sonographically indeterminate adnexal mass that are
being referred for clinical MR imaging. Investigators from the UW will be contributing coded
MR images and associated health information (US results, laboratory/pathology results) to the
EURAD trial. In addition, outcomes data on each patient will be sent at month 24 of the
research.
being referred for clinical MR imaging. Investigators from the UW will be contributing coded
MR images and associated health information (US results, laboratory/pathology results) to the
EURAD trial. In addition, outcomes data on each patient will be sent at month 24 of the
research.
An adnexal mass is the most common indication for gynaecological surgery. Pre operative
characterization is crucial and a scoring system would be useful to standardize the imaging
report and thus, improve patients management. Recently, the coordinating center developed the
first MR scoring system named ANDEXMR SCORING system in a retrospective study which is
accurate and reproducible. The objectives of this trial are to perform an external
prospective validation of this scoring system to evaluate its potential impact on therapeutic
strategy and to test its reproducibility.
This is a prospective large multicenter study. All patients with a sonographically
indeterminate adnexal mass referred for MR imaging will be included from each participating
center. One senior and one junior radiologists independently analyze the different MR
criteria to characterize adnexal masses. The reader will then classify the mass using ADNEXMR
SCORING system.
characterization is crucial and a scoring system would be useful to standardize the imaging
report and thus, improve patients management. Recently, the coordinating center developed the
first MR scoring system named ANDEXMR SCORING system in a retrospective study which is
accurate and reproducible. The objectives of this trial are to perform an external
prospective validation of this scoring system to evaluate its potential impact on therapeutic
strategy and to test its reproducibility.
This is a prospective large multicenter study. All patients with a sonographically
indeterminate adnexal mass referred for MR imaging will be included from each participating
center. One senior and one junior radiologists independently analyze the different MR
criteria to characterize adnexal masses. The reader will then classify the mass using ADNEXMR
SCORING system.
Inclusion Criteria:
- Patients 18 years of age or older
- With indeterminate ultrasonographic adnexal mass
Exclusion Criteria:
- Patients under 18 years of age
We found this trial at
1
site
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
Click here to add this to my saved trials
